SWM
RMD icon

SHP Wealth Management’s ResMed RMD Stock Holding History

SHP Wealth Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.92K Sell
15
-17
-53% -$3.52K ﹤0.01% 1290
2026
Q1 		$7.18K Buy
32
+28
+700% +$6.98K ﹤0.01% 983
2025
Q4 		$964 Buy
+4
New +$1.02K ﹤0.01% 1265

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

SHP Wealth Management's RMD Position: Q2 2026 in Review

SHP Wealth Management reduced its ResMed (RMD) stake by 53% in Q2 2026, selling an estimated $3.52K and leaving 15 shares worth $2.92K. The position accounts for ﹤0.01% of the portfolio, ranked #1290.

SHP Wealth Management first reported a position in RMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $7.18K in Q1 2026. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • SHP Wealth Management held 15 shares of ResMed worth $2.92K as of Q2 2026.
  • SHP Wealth Management sold 17 ResMed shares in Q2 2026, an estimated $3.52K.
  • ResMed made up ﹤0.01% of SHP Wealth Management's portfolio in Q2 2026, its #1290 holding.
  • SHP Wealth Management first reported a position in ResMed in Q4 2025 and has held it in 3 quarters since.
  • SHP Wealth Management's ResMed position peaked at $7.18K in Q1 2026.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on SHP Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.